[1]韩碧波,魏海东,郑 磊,等.经阴道彩色多普勒超声联合血清糖链抗原125和人附睾蛋白4水平检测对卵巢癌的诊断价值[J].新乡医学院学报,2019,36(10):971-974.[doi:10.7683/xxyxyxb.2019.10.016]
 HAN Bi-bo,WEI Hai-dong,ZHENG Lei,et al.Diagnostic value of transvaginal color Doppler sonography combined with serum carbohydrate antigen 125 and human epididymis protein 4 in ovarian cancer[J].Journal of Xinxiang Medical University,2019,36(10):971-974.[doi:10.7683/xxyxyxb.2019.10.016]
点击复制

经阴道彩色多普勒超声联合血清糖链抗原125和人附睾蛋白4水平检测对卵巢癌的诊断价值
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
36
期数:
2019年10
页码:
971-974
栏目:
临床研究
出版日期:
2019-10-05

文章信息/Info

Title:
Diagnostic value of transvaginal color Doppler sonography combined with serum carbohydrate antigen 125 and human epididymis protein 4 in ovarian cancer
作者:
韩碧波1魏海东1郑 磊1宋喜亮1田振英2王桂花3
(1.郑州市第二人民医院超声影像科,河南 郑州 450000;2.郑州市第二人民医院检验科,河南 郑州 450000;3.郑州市第二人民医院妇产科,河南 郑州 450000)
Author(s):
HAN Bi-bo1WEI Hai-dong1ZHENG Lei1SONG Xi-liang1TIAN Zhen-ying2WANG Gui-hua3
(1.Department of Ultrasound Imaging,the Second People′s Hospital of Zhengzhou City,Zhengzhou 450000,Henan Province,China;2.Department of Clinical Laboratory,the Second People′s Hospital of Zhengzhou City,Zhengzhou 450000,Henan Province,China;3.Department of Gynecology and Obstetrics,the Second People′s Hospital of Zhengzhou City,Zhengzhou 450000,Henan Province,China)
关键词:
经阴道彩色多普勒糖链抗原125人附睾蛋白4卵巢癌
Keywords:
transvaginal color Doppler sonographycarbohydrate antigen 125human epididymis protein 4ovarian cancer
分类号:
R737.31
DOI:
10.7683/xxyxyxb.2019.10.016
文献标志码:
A
摘要:
目的 探讨经阴道彩色多普勒超声(TVCDS)联合血清人附睾蛋白4(HE4)和糖链抗原125(CA125)水平检测在卵巢癌诊断中的应用价值。方法 选择2016年8月至2018年7月郑州市第二人民医院收治的41例卵巢癌患者(卵巢癌组)和41例卵巢良性病变患者(卵巢良性病变组)为研究对象,另选取41例同期健康体检者为健康对照组,所有受试者接受TVCDS检查,并检测血清CA125、HE4水平;对3组受试者Finkler超声评分及血清CA125、HE4水平进行比较,并分析TVCDS及血清CA125、HE4水平联合检测对卵巢癌的诊断价值。结果 卵巢癌组患者Finkler超声评分及血清CA125和HE4水平显著高于卵巢良性病变组和健康对照组(P<0.05),卵巢良性病变组患者Finkler超声评分及血清CA125和HE4水平显著高于健康对照组(P<0.05),Ⅲ+Ⅳ期卵巢癌患者Finkler超声评分及血清CA125和HE4水平显著高于Ⅰ+Ⅱ期患者(P<0.05)。TVCDS及血清CA125、HE4水平联合检测诊断卵巢癌的阳性率、准确度高于三者单独检测(P<0.05);但三者联合检测与单独检测诊断卵巢癌的特异度比较差异无统计学意义(P>0.05)。结论 TVCDS及血清CA125、HE4水平联合检测可有效提高卵巢癌阳性检出率及准确度,且能为卵巢癌病理分期提供参考。
Abstract:
Objective To investigate the value of transvaginal color Doppler sonography (TVCDS) combined with serum human epididymal protein 4 (HE4) and carbohydrate antigen 125 (CA125) in the diagnosis of ovarian cancer.Methods Forty-one patients with ovarian cancer (ovarian cancer group) and 41 patients with benign ovarian lesion (benign ovarian lesion group) in the Second People′s Hospital of Zhengzhou City from August 2016 to July 2018 were selected as the subjects,and forty-one healthy subjects in the same period were selected as healthy control group.All subjects were examined by TVCDS,and the levels of serum CA125 and HE4 were measured.The Finkler ultrasound score and the levels of serum CA125 and HE4 were compared among the three groups.The diagnostic value of TVCDS combined with the levels of serum CA125 and HE4 in ovarian cancer was analyzed.Results The Finkler ultrasound score and the levels of serum CA125 and HE4 in ovarian cancer group were significantly higher than those in the benign ovarian lesions group and the healthy control group (P<0.05).The Finkler ultrasound score and the levels of serum CA125 and HE4 in the benign ovarian lesion group were significantly higher than those in the healthy control group (P<0.05).The Finkler ultrasound score and the levels of serum CA125 and HE4 in patients with stage Ⅲ+Ⅳ ovarian cancer were significantly higher than those in patients with stage Ⅰ+Ⅱ ovarian cancer (P<0.05).The positive rate and accuracy of combined detection of TVCDS and the levels of serum CA125 and HE4 in the diagnosis of ovarian cancer were higher than those of single detection (P<0.05),but there was no significant difference in the specificity between combined detection and single detection of them in the diagnosis of ovarian cancer (P>0.05).Conclusion The combined detection of TVCDS and the levels of serum CA125 and HE4 can effectively improve the positive detection rate and accuracy of ovarian cancer,and can provide reference for pathological staging of ovarian cancer.

参考文献/References:

[1] 仝玉珠.腹腔镜下全面分期手术治疗早期卵巢癌疗效观察[J].新乡医学院学报,2018,35(9):804-806.
[2] 范群,李玉芳,范姜铱柔,等.血清HE4、TSGF和CA125联合检测诊断卵巢癌的价值[J].海南医学,2015,26(11):1634-1636.
[3] ZHANG F,ZHANG Z L.The diagnostic value of transvaginal sonograph (TVS),color Doppler,and serum tumor marker CA125,CEA,and AFP in ovarian cancer[J].Cell Biochem Biophys,2015,72(2):353-357.
[4] 辜卫红,胡天惠,薛涛.血清CA125、HE4联合阴道彩色多普勒在卵巢癌高危人群早期筛查中的临床价值[J].重庆医学,2017,46(12):1613-1615.
[5] 贺帅,马黎明,来艳君.HE4、CA125、SMRP检测联合ROMA在卵巢癌诊断中的应用[J].实用癌症杂志,2019,34(3):362-364,368.
[6] 王静,陶健,袁超.卵巢癌患者联合检测血清TK1、CA125的临床价值[J].中华全科医学,2014,12(6):975-976.
[7] 胡晓琳,王凤,魏佳宁,等.血清糖类抗原125、人附睾蛋白4及卵巢癌风险预测模型指数在卵巢恶性肿瘤诊断中的重要价值[J].中国老年学杂志,2017,37(4):908-909.
[8] 何树泉.血清HE4和CA125联合检测对卵巢癌的临床诊断价值探讨[J].数理医药学杂志,2016,29(11):1607-1608.
[9] HAMED E O,AHMED H,SEDEEK O B,et al.Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response[J].Diagn Pathol,2013,8(1):1-8.
[10] 高磊,刘晓霞,王泳心,等.血清糖类抗原125和人附睾蛋白4联合检测在卵巢癌诊断中的价值[J].中国老年学杂志,2016,36(12):2958-2959.
[11] GUERRIERO S,ALCAZAR J L,AJOSSA S,et al.Transvaginal color Doppler imaging in the detection of ovarian cancer in a large study population[J].Int J Gynecol Cancer,2010,20(5):781-786.
[12] 胥琳璟,郑晓霞,王斌,等.血清HE4、CA125联合TVCDS诊断早期卵巢癌的应用分析[J].河北医药,2017,39(5):668-670.
[13] 尹艳英,李娜,袁莉.血清HE4、CA125联合经阴道彩色多普勒超声诊断卵巢癌的临床价值[J].医学研究杂志,2014,43(6):132-134.
[14] QIU J J,LIU M H,ZHANG Z X,et al.Transvaginal color Doppler sonography predicts ovarian interstitial fibrosis and microvascular injury in women with ovarian endometriotic cysts[J].Acta Obstet Gynecol Scand,2012,91(5):605-612.
[15] 朱苏兰,鲁陈,何莹.血清CA125、HE4联合检测在卵巢癌早期诊断中的应用分析[J].现代诊断与治疗,2014,25(13):2998-2999.
[16] 梁建林,潘小萍,赵哓峰.血清 HE4与 CA125联合检测在早期卵巢癌诊断中的应用价值探讨[J].内蒙古医科大学学报,2015,37(6):580-582.
[17] GORP T V,CADRON I,DESPIERRE E,et al.HE4 and CA125 as a diagnostic test in ovarian cancer:prospective validation of the risk of ovarian malignancy algorithm[J].Br J Cancer,2011,104(5):863-870.
[18] 陈宗波,陈展泽,李国选,等.人血清附睾蛋白4和糖类抗原125联合检测对卵巢癌的诊断价值[J].检验医学与临床,2014,11(6):749-751.
[19] 雷震山,高鹏,吴金斌.联合检测血清HE4和CA125对卵巢癌患者的临床诊断价值探讨[J].国际检验医学杂志,2016,37(4):544-546.
[20] KONDALSAMY-CHENNAKESAVAN S,HACKETHAL A,BOW-TELL D,et al.Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4,CA125,and CEA and patient′s age[J].Gynecol Oncol,2013,129(3):467-471.

相似文献/References:

[1]任 波.胃癌患者化学治疗前后血清血红蛋白、血管内皮生长因子、癌胚抗原、糖链抗原19-9和糖链抗原125水平变化及临床意义[J].新乡医学院学报,2017,34(11):998.[doi:10.7683/xxyxyxb.2017.11.011]
 REN Bo.Clinic significant change of serum hemoglobin,vascular endothelial growth factor,carcinoembryonic antigen,carbohydrate antigen 19-9 & carbohydrate antigen 125 in gastric cancer patients chemotherapy[J].Journal of Xinxiang Medical University,2017,34(10):998.[doi:10.7683/xxyxyxb.2017.11.011]

更新日期/Last Update: 2019-10-05